Thiazolo-pyridopyrimidines: An in silico evaluation as a lead for CDK4/6 inhibition, synthesis and cytotoxicity screening against breast cancer cell lines
Introduction: Pyridopyrimidines belong to a class of compounds characterized by the presence of nitrogen as heteroatoms. These compounds exhibit diverse biological effects, particularly showing promise as anticancer agents, including actions that inhibit CDK4/6. Methods: We designed and synthesized...
Saved in:
| Main Authors: | Chaithra R Shetty, C. S. Shastry, Parasuraman P, Srinivas Hebbar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tabriz University of Medical Sciences
2024-07-01
|
| Series: | BioImpacts |
| Subjects: | |
| Online Access: | https://bi.tbzmed.ac.ir/PDF/bi-14-29951.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and synthesis of novel pyridopyrimidine moieties linked to coumarin ring of potentially active cytotoxic agents and their docking study
by: Nehal A. E. Youssef, et al.
Published: (2025-06-01) -
Identification and evaluation of pyrimidine based CDK6 inhibitors against glioblastoma using integrated computational approaches
by: Hina Manzoor, et al.
Published: (2025-07-01) -
Evaluation of cytotoxic potential of Callistemon leaf extracts against breast and colon cancer: Metabolomic, flow cytometry and in silico studies
by: Amira Y. Eissa, et al.
Published: (2025-06-01) -
Targeting CDK4/6 in Cancer: Molecular Docking and Cytotoxic Evaluation of <i>Thottea siliquosa</i> Root Extract
by: Maruthamuthu Rathinam Elakkiya, et al.
Published: (2025-07-01) -
Synthesis of some new N3 substituted 5-hydroxy-7-methyl-3H-thiazolo[4,5-b]pyridin-2-ones as potential biologically active compounds
by: T. I. Chaban, et al.
Published: (2019-07-01)